Frequently Asked Questions

What is tumor molecular profiling?
Molecular profiling is a panel of tests that is done to understand what is going on in a person’s tumor at the molecular level. The tests examine a panel of biomarkers that are involved in some of the cell signaling pathways that can be disrupted in cancer. These biomarkers can include proteins and genetic material (DNA and RNA) that may indicate whether your tumor is likely to be sensitive or resistant to certain cancer drugs. The biomarkers may also correlate with responses to drugs that are being tested in clinical trials.
What is a Tumor Blueprint?
The Clearity Foundation’s Tumor Blueprint is created for you based on the molecular profile of your tumor. Once the laboratories send the results of the biomarker tests, Clearity’s scientific team uses that information to create an interpretive report based on both clinical research evidence and patient data from the Diane Barton Database. The report provides a summary of therapy agents and clinical trial agents that are associated with potential clinical benefit, as well as details of the lab results and information about how your data compare to other patient results in our Database.
How will my doctor use the information in my Tumor Blueprint?
Your Tumor Blueprint will include a summary of therapy agents that are associated with potential clinical benefit, based on your molecular profile. Your physician can use this information, along with your medical history, the stage of your cancer, how much time passed between initial therapy and cancer recurrence, and other factors, to determine which therapy option to prioritize. You and your physician should also discuss any clinical trials for which you may be eligible.
Who should be tested?
Tumor profiling is most likely to be useful if one of the following statements describes your situation:
  • “I am having a recurrence since my first diagnosis and my doctor has planned another surgery or a biopsy to remove tumor tissue.”
  • “I have had a recurrence since my first diagnosis and another surgery or biopsy was performed to remove tumor tissue during the last year.”
What type of sample is needed?
All panels require a surgically-obtained sample of your tumor or tumor cells obtained from fluid that accumulates in your lungs or abdominal cavity. All of the tests in our panel can be performed on archived tumor samples.
Why do you only test tumor specimens that are obtained within the last year?
Studies have shown that tumors that survive chemotherapy treatment are often different from the original tumor. So,The Clearity Tumor Blueprint is generated using a sample that is removed as recently as possible so that it closely matches the cancer that is to be treated.
I’ve already had my surgery. Is it too late to get my Tumor Blueprint?
No. Our testing panel is performed on archived tumor samples.
How does my sample get to the laboratories for testing?
The Clearity Foundation will coordinate getting your sample to our clinical lab partners once we have all the necessary paperwork
What if I don’t live in the U.S.? Can I still get my Tumor Blueprint?
Contact the Clearity Foundation at (858) 657-0282 or for details and special arrangements
Once we have the test results, what’s next?
If your cancer continues to progress, the Clearity Foundation will help you and your doctor with treatment options, including facilitating choices for clinical trials. If your tests show that your cancer is likely to be sensitive to a particular drug or pathway we will work together with your doctor to find a protocol for your future treatment.
Why aren’t the drug companies doing this themselves? How does the Clearity Foundation help?
Drug companies perform targeted testing because the drug development process is so rigorous and a high volume of patients must be tested prior to the drug’s approval. Because the FDA requires statistical significance in these trials (a certain number of patients enrolled), drug companies develop for indications first where there is a high incidence rate, such as breast cancer (178,000 new diagnoses per year) rather than diseases such as ovarian cancer (22,000 new diagnoses per year).Signing up to have your blueprint determined will help encourage drug companies to conduct more clinical trials in ovarian cancer. By understanding the blueprint across the ovarian cancer population and how each one is different or similar, will help direct future treatments.
Who performs the biomarker testing?
The Clearity Foundation has established relationships with CLIA-certified clinical labs to perform the testing. Currently, our partners include Claris Life Sciences, Clarient, Inc., and Foundation Medicine, Inc.
How long does it take to get my Tumor Blueprint?
Once our clinical laboratory partners receive the sample, it typically takes 3-4 weeks to get the results from the testing. Your Tumor Blueprint will be sent to you approximately 2 days after we receive the laboratory results.
How much does it cost to get a Tumor Blueprint?
As a non-profit organization, the Clearity Foundation provides its patient support services free of charge. These services include test coordination, reporting and interpretation of test results, and identification of clinical trials for which you may be eligible.
The cost of the biomarker testing can vary depending on your insurance. We are committed to helping women with ovarian cancer make more informed treatment decisions regardless of their ability to pay. Our grant process exists as a way of identifying patients that need financial assistance to cover the cost of biomarker testing. If you are in need of financial help, please do not hesitate to fill out our Financial Assistance Form.
How can I support Clearity’s mission?
As a non-profit organization, the Clearity Foundation relies on charitable donations to support our Tumor Blueprint services, as well as our patient and physician educational programs. We encourage those interested in supporting our mission to make a donation, volunteer, or host or participate in a fundraising event.